rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2011-1-11
|
pubmed:abstractText |
To deliver rapid isoniazid (INH) and rifampicin (RMP) drug susceptibility testing (DST) close to the patient, we designed a decentralisation process for the microscopic observation drug susceptibility (MODS) assay in Peru and evaluated its reliability.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-10699023,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-12234129,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-12454186,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-15472289,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-17035648,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-17251409,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-17278058,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-18000545,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-18284841,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-18300380,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-18695217,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-18698423,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-19742330,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-20192726,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-20202307,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-20351778,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219684-20937190
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1815-7920
|
pubmed:author |
pubmed-author:AcurioMM,
pubmed-author:AsenciosLL,
pubmed-author:BonillaCC,
pubmed-author:CastilloEE,
pubmed-author:CoronelJJ,
pubmed-author:GamarraNN,
pubmed-author:HuamánTT,
pubmed-author:MendozaAA,
pubmed-author:MonroiYY,
pubmed-author:MooreD A JDA,
pubmed-author:ObregónGG,
pubmed-author:PereaMM,
pubmed-author:RoperMM,
pubmed-author:SalazarRR
|
pubmed:issnType |
Electronic
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
217-22, i
|
pubmed:dateRevised |
2011-11-10
|
pubmed:meshHeading |
pubmed-meshheading:21219684-Accreditation,
pubmed-meshheading:21219684-Antitubercular Agents,
pubmed-meshheading:21219684-Clinical Laboratory Techniques,
pubmed-meshheading:21219684-Humans,
pubmed-meshheading:21219684-Isoniazid,
pubmed-meshheading:21219684-Microbial Sensitivity Tests,
pubmed-meshheading:21219684-Microscopy,
pubmed-meshheading:21219684-Mycobacterium tuberculosis,
pubmed-meshheading:21219684-Observer Variation,
pubmed-meshheading:21219684-Peru,
pubmed-meshheading:21219684-Predictive Value of Tests,
pubmed-meshheading:21219684-Regional Health Planning,
pubmed-meshheading:21219684-Reproducibility of Results,
pubmed-meshheading:21219684-Rifampin,
pubmed-meshheading:21219684-Sensitivity and Specificity,
pubmed-meshheading:21219684-Sputum,
pubmed-meshheading:21219684-Tuberculosis, Multidrug-Resistant
|
pubmed:year |
2011
|
pubmed:articleTitle |
Reliability of the MODS assay decentralisation process in three health regions in Peru.
|
pubmed:affiliation |
Centro Nacional de Salud Pública, Instituto Nacional de Salud de Perú, Lima, Peru. mendozalberto@hotmail.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Evaluation Studies
|